The ScreenFect A from Alpha Laboratories combines high transfection efficiency with low cell toxicity, for DNA and siRNA transfection protocols.
Transfection of cells with plasmid DNA or siRNA has become a powerful tool in biological research.
The ScreenFectA transfection reagent is composed of new cationic lipids discovered by screening a library synthesised by Click Chemistry.
Cells in the logarithmic growth phase can be transfected in a simple, one-step protocol with no need to change media after transfection.
As it is compatible with serum, there is no need to switch to serum-free media when using ScreenFectA.
ScreenFectA has been successfully used to transfect both DNA and siRNA with high efficiency, according to Alpha Labs.
Compatible with a wide range of cells, ScreenFectA has been tested with primary cultures, mouse embryonic stem cells and a number of established cell lines.
